Evidence map›Paper›PMID 38067410›Full record

ArticleCancers2023

Correction: Méndez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells.

Carolina Méndez-Blanco, Flavia Fondevila, Paula Fernández-Palanca, Andrés García-Palomo, Jos van Pelt, Chris Verslype, Javier González-Gallego, José L Mauriz

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Carolina Méndez-BlancoInstitute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, 24071 León, Spain.ORCID 0000-0001-6378-2554
Flavia FondevilaInstitute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, 24071 León, Spain.ORCID 0000-0003-2881-704X
Paula Fernández-PalancaInstitute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, 24071 León, Spain.ORCID 0000-0001-9765-9562
Andrés García-PalomoService of Oncology, Complejo Asistencial Universitario de León, Calle Altos de Nava, s/n, 24001 León, Spain.
Jos van PeltLaboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven and University Hospitals Leuven and Leuven Cancer Institute (LKI), 3000 Leuven, Belgium.ORCID 0000-0001-6903-4338
Chris VerslypeLaboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven and University Hospitals Leuven and Leuven Cancer Institute (LKI), 3000 Leuven, Belgium.ORCID 0000-0003-3857-466X
Javier González-GallegoInstitute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, 24071 León, Spain.ORCID 0000-0002-4386-9342
José L MaurizInstitute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, 24071 León, Spain.ORCID 0000-0003-3160-8599
Instituto de Salud Carlos III · ESKU Leuven · BEComplejo Asistencial Universitario de Palencia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID38067410
PMCPMC10705316
OpenAlexW4389206092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.